Latest filing published 16 May 2017 for Medicinova INC, €5,099.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +89.3%Entry US$5.49 · Close at T+365 US$10.39
- +87.7%Entry US$5.60 · Close at T+365 US$10.51
- -16.4%Entry US$6.66 · Close at T+365 US$5.57
- -20.5%Entry US$6.83 · Close at T+365 US$5.43
- -1.7%Entry US$3.60 · Close at T+365 US$3.54
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Yutaka Kobayashi: trading record in brief
Yutaka Kobayashi discloses dealings in Medicinova Inc to SEC (Form 4). In total, 11 filings cover trades dated from 3 September 2014 to 15 May 2017.
Every open-market trade on record is a purchase: 11 purchases worth €401k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2017, the count stands at 2 purchases and no sales.
In size, the median ticket on the buying side is €25k. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month. For 11 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 73% of cases, with a median move of +7.5%. These figures describe past trades and do not predict future prices.
Most recently, on 16 May 2017, the filings show an open-market purchase worth €5,099 in Medicinova Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Yutaka Kobayashi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$5.602.0% of flowCommon StockSEC:0001683168-17-001289:0Canonical exit: 13 Aug 2017 (T+90)
- 24,000 shares@ US$5.6248.5% of flowCommon StockSEC:0001683168-17-001277:0Canonical exit: 10 Aug 2017 (T+90)
- 11,800 shares@ US$6.4426.4% of flowCommon StockSEC:0001683168-16-000124:0Canonical exit: 14 Dec 2016 (T+90)
- 10,000 shares@ US$6.6723.1% of flowCommon StockSEC:0001683168-16-000061:0Canonical exit: 8 Dec 2016 (T+90)
- 12,000 shares@ US$3.54Common StockSEC:0001019687-14-004664:0Canonical exit: 10 Mar 2015 (T+90)
- 10,000 shares@ US$3.07Common StockSEC:0001209191-14-071695:0Canonical exit: 24 Feb 2015 (T+90)
- 13,000 shares@ US$3.19Common StockSEC:0001019687-14-004453:0Canonical exit: 18 Feb 2015 (T+90)
- 10,000 shares@ US$2.95Common StockSEC:0001019687-14-003555:0Canonical exit: 10 Dec 2014 (T+90)
- 5,000 shares@ US$2.63Common StockSEC:0001019687-14-003461:0Canonical exit: 2 Dec 2014 (T+90)
- 100 shares@ US$2.66Common StockSEC:0001019687-14-003461:1Canonical exit: 2 Dec 2014 (T+90)
- 9,900 shares@ US$2.67Common StockSEC:0001019687-14-003461:2Canonical exit: 2 Dec 2014 (T+90)
11 of 11 declarations
